14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AZN.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for AstraZeneca PLC stock price on Thursday
(Updated on Apr 25, 2024)

Buy or Hold candidate since Apr 10, 2024 Gain 12.06% PDF

The AstraZeneca PLC stock price gained 5.94% on the last trading day (Thursday, 25th Apr 2024), rising from £11,352.00 to £12,026.00. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 2.60% from a day low at £11,790.00 to a day high of £12,096.00. The price has risen in 7 of the last 10 days and is up by 9.71% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately £49.55 billion.

Given the current short-term trend, the stock is expected to rise 9.40% during the next 3 months and, with a 90% probability hold a price between £11,324.16 and £13,156.56 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AZN.L Signals & Forecast

The AstraZeneca PLC stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at £11,231.14 and £10,672.97. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, February 12, 2024, and so far it has risen 26.58%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for AstraZeneca PLC stock

On the downside, the stock finds support just below today's level from accumulated volume at £10,450.00 and £10,036.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AstraZeneca PLC finds support just below today's level at £10,450.00. If this is broken, then the next support from accumulated volume will be at £10,036.00 and £9,724.00.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved £306.00 (2.60%) between high and low. For the last week, the stock has had daily average volatility of 1.89%.

The AstraZeneca PLC stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs. Since the AstraZeneca PLC has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: £11,636.36 (-3.24%) (This stock has low daily movements and this gives low risk. The RSI14 is 88 and this increases the risk substantially. There is a buy signal from a pivot bottom found 51 days ago.)

Trading Expectations (AZN.L) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect AstraZeneca PLC to open at £11,970.67, and during the day (based on 14 day Average True Range), to move between £11,799.27 and £12,252.73, which gives a possible trading interval of +/-£226.73 (+/-1.89%) up or down from last closing price. If AstraZeneca PLC takes out the full calculated possible swing range there will be an estimated 3.77% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ £10,450.00, some £1,576.00 (13.10%) from the current price of £12,026.00, our system finds the risk reward attractive.

Is AstraZeneca PLC stock A Buy?

AstraZeneca PLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for AstraZeneca PLC of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
£11,970.67 ( 0.460%) £12,026.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AZN.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12,276.67 2.08 %
R2 12,159.77 1.11 %
R1 12,087.56 0.512 %
Current price: 12,026.00
Support S1 11,853.77 -1.43 %
S2 11,781.56 -2.03 %
S3 11,664.67 -3.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 12,026.00
Support S1 10,450.00 -13.10%
S2 10,036.00 -16.55%
S3 9,724.00 -19.14%

AZN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 22, 2024 Feb 22, 2024 Mar 25, 2024 £156.00 1.50%
2 Feb 09, 2023 Feb 23, 2023 Mar 27, 2023 £162.80 1.45%
3 Jul 29, 2022 Aug 11, 2022 Sep 12, 2022 £76.40 0.719%
4 Feb 10, 2022 Feb 24, 2022 Mar 28, 2022 £145.30 1.47%
5 Jul 29, 2021 Aug 12, 2021 Sep 13, 2021 £64.80 0.80%

FAQ

What is the symbol for AstraZeneca PLC Stock and on which exchange is it traded?
The symbol for AstraZeneca PLC is AZN.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell AstraZeneca PLC Stock?
AstraZeneca PLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy AstraZeneca PLC Stock?
AstraZeneca PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AstraZeneca PLC Stock.

What's the current price of AstraZeneca PLC Stock?
As of the end of day on the Apr 25, 2024, the price of an AstraZeneca PLC (AZN.L) share was £12,026.00.

What is the 52-week high and low for AstraZeneca PLC Stock?
The 52-week high for AstraZeneca PLC Stock is £12,210.00 and the 52-week low is £9,463.00.

What is the market capitalization of AstraZeneca PLC Stock?
As of the Apr 25, 2024, the market capitalization of AstraZeneca PLC is 186.431B.

When is the next earnings date for AstraZeneca PLC?
The upcoming earnings date for AstraZeneca PLC is Jul 25, 2024.
Click to get the best stock tips daily for free!

About AstraZeneca PLC

AstraZeneca PLC AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/... AZN.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT